Cargando…
Development of bullous pemphigoid during treatment of psoriasis with ustekinumab: a case report and literature review
Ustekinumab is a biological therapy that has been approved for treating moderate-to-severe psoriasis. Although injection site reactions, nasopharyngitis, headaches, and infections are the common adverse events associated with ustekinumab, the development of bullous pemphigoid (BP) is also thought to...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240285/ https://www.ncbi.nlm.nih.gov/pubmed/37283625 http://dx.doi.org/10.3389/fmed.2023.1171802 |